Korro Bio, Inc. (KRRO)
NASDAQ: KRRO · Real-Time Price · USD
12.80
-0.04 (-0.31%)
Apr 28, 2026, 4:00 PM EDT - Market closed

Korro Bio Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-117.26-83.58-81.17-58.03-21.96
Depreciation & Amortization
4.283.573.632.511.6
Loss (Gain) From Sale of Assets
0.060.360.07-0.01
Asset Writedown & Restructuring Costs
30.89----
Loss (Gain) From Sale of Investments
-0.49-1.78-0.08-0.150.02
Stock-Based Compensation
7.664.462.381.140.81
Other Operating Activities
0.733.313.611.51-13.47
Change in Accounts Receivable
0.73-1.7---
Change in Accounts Payable
-2.31-1.343.11.760.06
Change in Unearned Revenue
-1.599.43---0.69
Change in Other Net Operating Assets
-1.257.21.18-2.391.53
Operating Cash Flow
-78.56-60.07-67.28-53.65-32.09
Capital Expenditures
-0.52-17.9-7.84-5.21-4.45
Sale of Property, Plant & Equipment
----0.01
Investment in Securities
44.51-105.451916.27-35.07
Investing Cash Flow
43.99-123.3511.1611.06-39.5
Issuance of Common Stock
0.6969.36154.550.060.03
Other Financing Activities
---12.25-0.04-0.03
Financing Cash Flow
0.6969.36187.760.02115.95
Foreign Exchange Rate Adjustments
0.06-0---
Net Cash Flow
-33.82-114.07131.64-42.5744.35
Free Cash Flow
-79.08-77.98-75.12-58.86-36.54
Free Cash Flow Margin
-1237.16%-3433.55%---
Free Cash Flow Per Share
-8.42-8.74-49.12-230.65-8.22
Cash Income Tax Paid
00.140.030.01-
Levered Free Cash Flow
-49.36-69.99-47.69-38.2-
Unlevered Free Cash Flow
-49.36-69.99-47.69-38.2-
Change in Working Capital
-4.4313.594.28-0.630.9
Source: S&P Capital IQ. Standard template. Financial Sources.